Rotterdam Study cohort (n=2412) | Amsterdam UMC cohort (n=859) | Combined cohort (N=3271) | |
Age (years) | 69.6±6.7 | 46.3±11.8 | 63.3±13.3 |
Female (%) | 1247 (51.7) | 488 (56.8) | 1735 (53.0) |
BMI (kg/m2) | 27.6±3.9 | 26.5±4.4 | 27.4±4.1 |
Smoking (current) | 365 (15.1) | 193 (22.5) | 558 (17.1) |
Use of antihypertensive medication (%) | 964 (40.0) | 149 (17.3) | 1113 (34.0) |
Non-HDL cholesterol (mmol/L) | 4.2±1.0 | 3.9±1.1 | 4.1±1.0 |
Lipoprotein(a) (mg/dL) | 12.5 (5.4–37.4) | 12.6 (5.3–35.2) | 12.5 (5.3–36.7) |
Presence of aortic valve calcification (%) | 798 (33.1) | 46 (5.4) | 844 (25.8) |
Data are depicted as mean±SD, median (IQR) or number (percentage).
Data are original, non-imputed values.
BMI, body mass index; HDL, high-density lipoprotein; UMC, University Medical Centers.